Stay updated on Nivolumab With BRAF/MEK Inhibitors in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab With BRAF/MEK Inhibitors in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab With BRAF/MEK Inhibitors in Melanoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4, representing a minor revision of the page's metadata. This update does not alter study content, eligibility criteria, or user-facing functionality.
    Difference
    0.0%
    Check dated 2026-07-26T19:10:56.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The revision label on the page was updated to v3.6.3, replacing the previous v3.6.2. This indicates a newer version of the study record.
    Difference
    0.0%
    Check dated 2026-07-05T05:00:14.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.2, replacing the previous v3.6.0. This indicates a maintenance update to the site without altering the study content.
    Difference
    0.0%
    Check dated 2026-06-28T01:33:54.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The study page now explicitly notes that recruitment is no longer open. It also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment header, along with a site-wide Revision: v3.6.0 tag.
    Difference
    1.0%
    Check dated 2026-06-13T17:16:15.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The study page shows a revised version number, from v3.5.4 to v3.5.5. This indicates a minor update to the record without altering the actual study data or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-06-06T14:06:29.000Z thumbnail image
  9. Check
    85 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3. This indicates a minor administrative update to the page's versioning rather than a change to study details.
    Difference
    0.0%
    Check dated 2026-05-15T23:37:49.000Z thumbnail image

Stay in the know with updates to Nivolumab With BRAF/MEK Inhibitors in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab With BRAF/MEK Inhibitors in Melanoma Clinical Trial page.